These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22107728)

  • 1. Disorder-specific effects of polymorphisms at opposing ends of the Insulin Degrading Enzyme gene.
    Bartl J; Scholz CJ; Hinterberger M; Jungwirth S; Wichart I; Rainer MK; Kneitz S; Danielczyk W; Tragl KH; Fischer P; Riederer P; Grünblatt E
    BMC Med Genet; 2011 Nov; 12():151. PubMed ID: 22107728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms within insulin-degrading enzyme (IDE) gene determine insulin metabolism and risk of type 2 diabetes.
    Rudovich N; Pivovarova O; Fisher E; Fischer-Rosinsky A; Spranger J; Möhlig M; Schulze MB; Boeing H; Pfeiffer AF
    J Mol Med (Berl); 2009 Nov; 87(11):1145-51. PubMed ID: 19809796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-degrading enzyme and Alzheimer disease: a genetic association study in the Han Chinese.
    Bian L; Yang JD; Guo TW; Sun Y; Duan SW; Chen WY; Pan YX; Feng GY; He L
    Neurology; 2004 Jul; 63(2):241-5. PubMed ID: 15277615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.
    Ertekin-Taner N; Allen M; Fadale D; Scanlin L; Younkin L; Petersen RC; Graff-Radford N; Younkin SG
    Hum Mutat; 2004 Apr; 23(4):334-42. PubMed ID: 15024728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels.
    Gu HF; Efendic S; Nordman S; Ostenson CG; Brismar K; Brookes AJ; Prince JA
    Diabetes; 2004 Aug; 53(8):2137-42. PubMed ID: 15277398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between variants in IDE-KIF11-HHEX and plasma amyloid β levels.
    Reitz C; Cheng R; Schupf N; Lee JH; Mehta PD; Rogaeva E; St George-Hyslop P; Mayeux R
    Neurobiol Aging; 2012 Jan; 33(1):199.e13-7. PubMed ID: 20724036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-degrading enzyme is genetically associated with Alzheimer's disease in the Finnish population.
    Vepsäläinen S; Parkinson M; Helisalmi S; Mannermaa A; Soininen H; Tanzi RE; Bertram L; Hiltunen M
    J Med Genet; 2007 Sep; 44(9):606-8. PubMed ID: 17496198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of insulin degrading enzyme gene polymorphisms with Alzheimer's disease: a meta-analysis.
    Cheng H; Wang L; Shi T; Shang Y; Jiang L
    Int J Neurosci; 2015 May; 125(5):328-35. PubMed ID: 25105907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of insulin degrading enzyme gene are not associated with Alzheimer's disease.
    Boussaha M; Hannequin D; Verpillat P; Brice A; Frebourg T; Campion D
    Neurosci Lett; 2002 Aug; 329(1):121-3. PubMed ID: 12161276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility.
    Groves CJ; Wiltshire S; Smedley D; Owen KR; Frayling TM; Walker M; Hitman GA; Levy JC; O'Rahilly S; Menzel S; Hattersley AT; McCarthy MI
    Diabetes; 2003 May; 52(5):1300-5. PubMed ID: 12716770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein.
    Farris W; Mansourian S; Leissring MA; Eckman EA; Bertram L; Eckman CB; Tanzi RE; Selkoe DJ
    Am J Pathol; 2004 Apr; 164(4):1425-34. PubMed ID: 15039230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-degrading enzyme, apolipoprotein E, and Alzheimer's disease.
    Edland SD
    J Mol Neurosci; 2004; 23(3):213-7. PubMed ID: 15181249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism Rs2421943 of the Insulin-Degrading Enzyme Gene and the Risk of Late-Onset Alzheimer's Disease.
    Šerý O; Zeman T; Hálová A; Janout V; Janoutová J; Lochman J; Balcar VJ
    Curr Alzheimer Res; 2022; 19(3):236-245. PubMed ID: 35236268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoter polymorphisms which modulate insulin degrading enzyme expression may increase susceptibility to Alzheimer's disease.
    Zuo X; Jia J
    Brain Res; 2009 Jan; 1249():1-8. PubMed ID: 18996360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin degrading enzyme contributes to the pathology in a mixed model of Type 2 diabetes and Alzheimer's disease: possible mechanisms of IDE in T2D and AD.
    Li H; Wu J; Zhu L; Sha L; Yang S; Wei J; Ji L; Tang X; Mao K; Cao L; Wei N; Xie W; Yang Z
    Biosci Rep; 2018 Feb; 38(1):. PubMed ID: 29222348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polymorphisms of the insulin-degrading enzyme gene and late-onset Alzheimer disease.
    Wang S; He F; Wang Y
    J Geriatr Psychiatry Neurol; 2015 Jun; 28(2):94-8. PubMed ID: 25414272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No association between the insulin degrading enzyme gene and Alzheimer's disease in a Japanese population.
    Sakai A; Ujike H; Nakata K; Takehisa Y; Imamura T; Uchida N; Kanzaki A; Yamamoto M; Fujisawa Y; Okumura K; Kuroda S
    Am J Med Genet B Neuropsychiatr Genet; 2004 Feb; 125B(1):87-91. PubMed ID: 14755451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.
    Carrasquillo MM; Belbin O; Zou F; Allen M; Ertekin-Taner N; Ansari M; Wilcox SL; Kashino MR; Ma L; Younkin LH; Younkin SG; Younkin CS; Dincman TA; Howard ME; Howell CC; Stanton CM; Watson CM; Crump M; Vitart V; Hayward C; Hastie ND; Rudan I; Campbell H; Polasek O; Brown K; Passmore P; Craig D; McGuinness B; Todd S; Kehoe PG; Mann DM; Smith AD; Beaumont H; Warden D; Holmes C; Heun R; Kölsch H; Kalsheker N; Pankratz VS; Dickson DW; Graff-Radford NR; Petersen RC; Wright AF; Younkin SG; Morgan K
    PLoS One; 2010 Jan; 5(1):e8764. PubMed ID: 20098734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
    Nowotny P; Hinrichs AL; Smemo S; Kauwe JS; Maxwell T; Holmans P; Hamshere M; Turic D; Jehu L; Hollingworth P; Moore P; Bryden L; Myers A; Doil LM; Tacey KM; Gibson AM; McKeith IG; Perry RH; Morris CM; Thal L; Morris JC; O'Donovan MC; Lovestone S; Grupe A; Hardy J; Owen MJ; Williams J; Goate A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Jul; 136B(1):62-8. PubMed ID: 15858813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.